JTCVS techniques · 2026
Establishment of a feasible surgical strategy for aortoesophageal fistula.
СтатьяНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Yamanaka Katsuhiro, Okada Kenji, Sakaguchi Kazunori, Okada Tasuku, Shiraki Hironaga, Kawabata Ryo, Karaki Jun, Koterazawa Yasufumi, Oyama Noriko, Henmi Soichiro, Goto Hironobu, Takahashi Hiroaki, Okita Yutaka
Аннотация
OBJECTIVES: Aortoesophageal fistula (AEF) represents one of the most challenging and devastating complications in aortic surgery. This study aimed to evaluate the feasibility, technical considerations, and clinical outcomes of our standardized multidisciplinary strategy for AEF, which has been consistently applied since 2008.
METHODS: This retrospective study included 21 patients with AEF who underwent open surgery from January 2008 to September 2025. The primary end point was freedom from infection-related death, reflecting the central role of infection control in AEF management. Secondary end points included hospital mortality, overall survival, and the esophageal reconstruction rate.
RESULTS: The mean age was 69.3 ± 11.2 years. Hospital mortality after open surgery was 26.9%. The 10-year overall survival and freedom from infection-related death were 38.4 ± 13.2% and 89.7 ± 6.8%, respectively. After implementation of our current standardized strategy in 2008, no recurrent infections were observed, and 10 patients successfully completed reconstruction.
CONCLUSIONS: Although hospital mortality remains substantial, long-term outcomes were favorable. The current multidisciplinary surgical strategy was associated with improved infection-related outcomes, with no recurrent infections observed.
METHODS: This retrospective study included 21 patients with AEF who underwent open surgery from January 2008 to September 2025. The primary end point was freedom from infection-related death, reflecting the central role of infection control in AEF management. Secondary end points included hospital mortality, overall survival, and the esophageal reconstruction rate.
RESULTS: The mean age was 69.3 ± 11.2 years. Hospital mortality after open surgery was 26.9%. The 10-year overall survival and freedom from infection-related death were 38.4 ± 13.2% and 89.7 ± 6.8%, respectively. After implementation of our current standardized strategy in 2008, no recurrent infections were observed, and 10 patients successfully completed reconstruction.
CONCLUSIONS: Although hospital mortality remains substantial, long-term outcomes were favorable. The current multidisciplinary surgical strategy was associated with improved infection-related outcomes, with no recurrent infections observed.